secwatch.observer — SEC 8-K summary
======================================

Issuer:     KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
CIK:        0001877184
Form:       8-K
Filed at:   2025-09-11T23:59:59+00:00
Accession:  0000950170-25-114228
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kestra Medical Q1 FY26 revenue up 52% to $19.4M; raises FY26 guidance to $88M
-----------------------------------------------------------------------------

- Revenue $19.4M (+52% YoY); gross margin expanded to 45.7% from 32.9%.
- GAAP net loss $25.8M vs $20.3M; adjusted EBITDA loss $19.4M vs $15.7M.
- 4,205 prescriptions for ASSURE system, up 51% YoY; driven by new accounts and in-network mix.
- FY26 revenue guidance raised to $88M, representing 47% growth over FY25.
- Cash and equivalents $201.2M as of July 31, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1877184/000095017025114228/0000950170-25-114228-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1877184/000095017025114228/ck0001877184-20250911.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-114228

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer